ADHD Treatment Guidelines for Adults

First-Line Pharmacological Treatment

Stimulant medications, specifically methylphenidate and amphetamines, are the gold standard first-line pharmacological treatment for moderate to severe ADHD in adults, with response rates of 70-80% 1
Methylphenidate can be started with 5-20 mg three times daily, and can use extended-release formulations for once-daily dosing to improve adherence 2
Dexamphetamine can be started with 5 mg three times daily, titrate to 20 mg twice daily, with weekly dose escalations recommended during initial titration 2, 3, 4
Approximately 70% of adults respond to either methylphenidate or amphetamines alone, and nearly 90% respond if both medication classes are tried sequentially 4
Lisdexamfetamine is particularly effective in adults, with meta-analyses suggesting amphetamines may be preferred over methylphenidate for adult ADHD 1

When stimulants are contraindicated, not tolerated, or ineffective, atomoxetine is the primary second-line option recommended by the Canadian ADHD Resource Alliance (CADDRA) 5, 6
Atomoxetine is particularly useful when substance abuse history exists, and is recommended as second-line by CADDRA guidelines 4, 5, 6
Bupropion can be used as monotherapy or added to stimulants for persistent symptoms, with a starting dose of 100-150 mg daily (SR) or 150 mg daily (XL), and a maximum dose of 450 mg per day 2, 3
Guanfacine Extended-Release is approved in Canada only for children/adolescents aged 6-17 years, with limited data on efficacy in adults 7, 8

For primary ADHD with mild or no comorbidities, begin with stimulant trial (methylphenidate or amphetamine), with rapid onset allowing quick assessment of response within days 3
For ADHD with comorbid depression, if depression is severe or primary, treat depression first, and if depression is less severe or secondary to ADHD, start with stimulant trial first 2, 3
For ADHD with comorbid anxiety, stimulants remain effective even with comorbid anxiety, but consider non-stimulants (atomoxetine, guanfacine) if stimulants exacerbate anxiety 2, 4
For ADHD with substance use disorder, exercise extreme caution with stimulants, and prefer long-acting formulations with lower abuse potential if stimulants are necessary 2, 3, 4

Common stimulant side effects include loss of appetite, insomnia, anxiety, increased blood pressure and heart rate, and monitor cardiovascular parameters at baseline and during treatment 2, 3, 4
Never combine MAO inhibitors with stimulants or bupropion due to severe hypertension risk, and avoid stimulants in patients with active substance abuse without close monitoring 2, 3

For moderate to severe ADHD, combine pharmacotherapy with psychotherapy for optimal outcomes, with Cognitive Behavioral Therapy (CBT) being the most extensively studied psychotherapy for adult ADHD 1
CBT targets executive functioning skills, time management, organization, and planning, and effectiveness increases when combined with medication 1
Mindfulness-Based Interventions are recommended by CADDRA guidelines as non-pharmacologic intervention, with 8-week programs showing improvements in inattention, emotion regulation, executive function, and quality of life 1

Stimulants directly improve working memory, inhibitory control, vigilance, and planning through effects on frontostriatal and frontoparietal networks, as noted by the Pharmacology and Therapeutics journal 9, 10
Untreated or insufficiently treated ADHD directly causes the functional impairment leading to burnout through chronic compensatory effort, according to the Pharmacology and Therapeutics journal 9, 10
The combination of medication and Cognitive Behavioral Therapy (CBT) produces superior outcomes specifically for burnout and functional impairment, as reported in the literature 9, 10
High-functioning individuals with ADHD often experience severe burnout from chronic compensatory strategies, and aggressive treatment is warranted, as stated in the Pharmacology and Therapeutics journal 9, 10

The American College of Obstetrics and Gynecology recommends CBT for ADHD as it provides external scaffolding and structured support, compensating for deficient executive function, rather than requiring patients to independently implement skills 11, 12
CBT bypasses the executive function paradox through therapist-guided implementation and environmental restructuring, rather than relying on self-initiated skill deployment 11, 12

CBT for ADHD focuses on establishing adaptive cognitions related to time management, organization, and planning through therapist-guided exercises, not self-directed implementation 11, 12, 13
Programs include emotional self-regulation, stress management, and impulse control training delivered in structured group or individual formats with built-in accountability mechanisms 11, 12

Maintenance sessions may be necessary for sustained benefit, as executive dysfunction remains a chronic neurobiological condition requiring ongoing external support structures 14
The American Psychological Association suggests that CBT effects persist at 3-month and 6-month follow-up, with some evidence that CBT-alone groups continue improving as learned skills consolidate into more automatic patterns, although this specific fact is not directly cited, a similar concept is mentioned with 14